Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

electroCore, Inc. Common Stock

ECOR Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of ECOR by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
ECOR Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
ECOR Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
ECOR Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in ECOR holdings by institutional investors

Quarterly net insider trading by ECOR's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Former government officials who have lobbied for ECOR

7 former government officials from 4 congressional offices at 2 lobbying firms have lobbied for ECOR, most recently Jul 20, 2026.

  • Mark Lindsay House U.S House Staff Formerly U.S House Staff · BELL & LINDSAY, INC. · Jul 20, 2026
  • Ed Whitfield
    Jeffery Mortier House Prof Staff on E&C Cmte, LA Rep Whitfield and Intern Devin Nunes Formerly with Ed Whitfield · FARRAGUT PARTNERS LLP · Apr 20, 2022
  • Edward Whitfield House U.S. Representative (21 yrs.) Formerly U.S. Representative (21 yrs.) · FARRAGUT PARTNERS LLP · Apr 20, 2022
  • John B. Breaux
    Sarah Walter Senate Former Legislative Director/Chief Counsel, Sen. John Breaux Formerly with John B. Breaux · FARRAGUT PARTNERS LLP · Apr 20, 2022
  • Joe Barton
    Jeff Mackinnon House LD & LA Rep. Joe Barton (RTexas) Formerly with Joe Barton · FARRAGUT PARTNERS LLP · Apr 20, 2022
  • Wayne T. Gilchrest
    J Walsh House LD Rep. Wayne Gilchrest and LA Rep. Jack Buechner Formerly with Wayne T. Gilchrest · FARRAGUT PARTNERS LLP · Apr 20, 2022
  • Kristen O'Neill Other Health Policy Advisory, LA, Staff Assistant Gene Greene (D-TX) Staff Assistant GK Butterfield (D-NC) Formerly Health Policy Advisory, LA, Staff Assistant Gene Greene (D-TX) Staff Assistant G · FARRAGUT PARTNERS LLP · Jan 20, 2022

ECOR Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

ECOR Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
ECOR Income Statement
ECOR Balance Sheet
ECOR Cash Flow
U.S. Patents

New ECOR patent grants

  • Patent Title: Nerve stimulation device Jan. 06, 2026
  • Patent Title: Nerve stimulation device Aug. 26, 2025
  • Patent Title: Electrical treatment of bronchial constriction Nov. 21, 2017
  • Patent Title: Devices and methods for non-invasive capacitive electrical stimulation and their use for vagus nerve stimulation on the neck of a patient Aug. 01, 2017
  • Patent Title: Nerve stimulator system May. 23, 2017
  • Patent Title: Non-invasive vagal nerve stimulation to treat disorders Apr. 18, 2017
  • Patent Title: Systems and methods for vagal nerve stimulation Feb. 14, 2017
  • Patent Title: Non-invasive treatment of bronchial constriction Jan. 31, 2017
  • Patent Title: Systems and methods for electrical stimulation of sphenopalatine ganglion and other branches of cranial nerves Oct. 18, 2016
  • Patent Title: Devices and methods for treating medical disorders with evoked potentials and vagus nerve stimulation Aug. 30, 2016
  • Patent Title: Non-invasive vagal nerve stimulation to treat disorders Aug. 16, 2016
  • Patent Title: Non-invasive magnetic or electrical nerve stimulation to treat gastroparesis, functional dyspepsia, and other functional gastrointestinal disorders Aug. 02, 2016
  • Patent Title: Non-invasive vagal nerve stimulation to treat disorders Jul. 26, 2016
  • Patent Title: Mobile phone using non-invasive nerve stimulation Jun. 28, 2016
  • Patent Title: Non-invasive vagal nerve stimulation to treat disorders Jun. 07, 2016
  • Patent Title: Electrical stimulation treatment of hypotension May. 17, 2016
  • Patent Title: Devices and methods for non-invasive electrical stimulation and their use for vagal nerve stimulation on the neck of a patient May. 10, 2016
  • Patent Title: Non-invasive treatment of bronchial constriction May. 03, 2016
  • Patent Title: Methods and apparatus for treating anaphylaxis using electrical modulation Mar. 15, 2016
  • Patent Title: Devices and methods for monitoring non-invasive vagus nerve stimulation Feb. 09, 2016
  • Patent Title: Medical self-treatment using non-invasive vagus nerve stimulation Feb. 02, 2016
  • Patent Title: Devices and methods for non-invasive capacitive electrical stimulation and their use for vagus nerve stimulation on the neck of a patient Jan. 26, 2016
  • Patent Title: Magnetic stimulation devices and methods of therapy Jan. 12, 2016
  • Patent Title: Methods and devices for treating primary headache Jan. 12, 2016
  • Patent Title: Non-invasive magnetic or electrical nerve stimulation to treat gastroparesis, functional dyspepsia, and other functional gastrointestinal disorders Jan. 12, 2016
  • Patent Title: Nerve stimulator system Dec. 08, 2015
  • Patent Title: Devices and methods for non-invasive capacitive electrical stimulation and their use for vagus nerve stimulation on the neck of a patient Nov. 03, 2015
  • Patent Title: Systems and methods for electrical stimulation of sphenopalatine ganglion and other branches of cranial nerves Nov. 03, 2015
  • Patent Title: Non-invasive electrical and magnetic nerve stimulators used to treat overactive bladder and urinary incontinence Nov. 03, 2015
  • Patent Title: Non-invasive vagus nerve stimulation devices and methods to treat or avert atrial fibrillation Sep. 08, 2015
  • Patent Title: Non-invasive treatment of a medical condition by vagus nerve stimulation Sep. 01, 2015
  • Patent Title: Non-invasive methods and devices for inducing euphoria in a patient and their therapeutic application Jul. 28, 2015
  • Patent Title: Devices and methods for non-invasive capacitive electrical stimulation and their use for vagus nerve stimulation on the neck of a patient Jun. 30, 2015
  • Patent Title: Methods and devices for treating primary headache May. 26, 2015
  • Patent Title: Non-invasive treatment of bronchial constriction May. 19, 2015
  • Patent Title: Electrical stimulation treatment of bronchial constriction May. 19, 2015
  • Patent Title: Methods and devices for treating primary headache Apr. 28, 2015
  • Patent Title: Methods and devices for treating primary headache Apr. 21, 2015
  • Patent Title: Non-invasive vagal nerve stimulation to treat disorders Mar. 17, 2015
  • Patent Title: Non-invasive vagal nerve stimulation to treat disorders Mar. 17, 2015
  • Patent Title: Magnetic stimulation devices and methods of therapy Mar. 03, 2015
  • Patent Title: Electrical stimulation treatment of hypotension Feb. 03, 2015
  • Patent Title: Methods and apparatus for treating anaphylaxis using electrical modulation Jan. 13, 2015
  • Patent Title: Non-invasive vagal nerve stimulation to treat disorders Dec. 23, 2014
  • Patent Title: Devices and methods for non-invasive capacitive electrical stimulation and their use for vagus nerve stimulation on the neck of a patient Dec. 16, 2014
  • Patent Title: Systems and methods for selectively applying electrical energy to tissue Nov. 04, 2014
  • Patent Title: Devices and methods for non-invasive capacitive electrical stimulation and their use for vagus nerve stimulation on the neck of a patient Oct. 28, 2014
  • Patent Title: Device and methods for non-invasive electrical stimulation and their use for vagal nerve stimulation Oct. 28, 2014
  • Patent Title: Non-invasive treatment of neurodegenerative diseases Oct. 21, 2014
  • Patent Title: Stimulator Oct. 16, 2012
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to ECOR from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
ECOR News

Recent insights relating to ECOR

CNBC Recommendations

Recent picks made for ECOR stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ECOR

ECOR Analyst Ratings

ECOR Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
ECOR Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $ECOR stock a Buy, Sell, or Hold?

  • What is the price target for $ECOR stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

ECOR Top Shareholders
Shareholder
Shares Held
ECOR Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $ECOR stock?

  • Who owns the most shares of $ECOR stock?

  • What funds own $ECOR stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

ECOR Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view ECOR Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About ECOR

electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.

  • Address Rockaway, NJ
  • Market Cap 103.0 million
  • Employees 83
  • Industrial Classification Electromedical & Electrotherapeutic Apparatus

electroCore, Inc. Common Stock (ECOR) Historical Stock Prices

electroCore, Inc. Common Stock (ECOR) closed at $11.42 on September 23, 2026. Over the past year its adjusted close ranged from $4.42 to $12.29. Daily prices go back to June 22, 2018, 2,074 trading days in all.

  • 1 month+18.34%
  • 3 months+50.86%
  • Year to date+154.63%
  • 1 year+120.89%
  • 3 years+114.66%
  • 5 years-34.36%
  • Max-96.16%
See every congressional and insider trade on the ECOR price chart

Quiver Premium charts ECOR's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 23, 2026 12.04 12.13 11.25 11.42 11.42 113,311
Sep 22, 2026 12.18 12.70 11.99 12.29 12.29 126,240
Sep 21, 2026 11.74 12.12 11.35 11.99 11.99 120,278
Sep 18, 2026 11.35 11.68 11.14 11.68 11.68 97,938
Sep 17, 2026 10.80 11.93 10.46 11.38 11.38 215,123
Sep 16, 2026 10.07 10.68 9.86 10.65 10.65 137,359
Sep 15, 2026 9.78 10.29 9.45 10.05 10.05 86,498
Sep 14, 2026 9.60 9.91 9.47 9.76 9.76 38,521
Sep 11, 2026 9.19 9.99 9.19 9.62 9.62 40,224
Sep 10, 2026 8.70 9.40 8.70 9.19 9.19 85,445
Sep 9, 2026 8.90 9.19 8.90 8.99 8.99 26,977
Sep 8, 2026 9.08 9.19 8.87 9.08 9.08 24,201
Sep 4, 2026 9.18 9.41 9.02 9.21 9.21 19,956
Sep 3, 2026 9.50 9.70 8.96 9.21 9.21 32,746
Sep 2, 2026 9.09 9.63 8.75 9.51 9.51 82,220
Sep 1, 2026 9.32 9.55 8.99 9.05 9.05 180,055
Aug 31, 2026 9.51 9.87 9.20 9.49 9.49 96,431
Aug 28, 2026 9.63 9.99 9.22 9.62 9.62 87,117
Aug 27, 2026 10.59 10.67 9.66 9.71 9.71 64,102
Aug 26, 2026 9.45 10.35 9.45 10.35 10.35 78,008
Aug 25, 2026 9.56 9.97 9.23 9.47 9.47 109,294
Aug 24, 2026 10.52 10.52 9.48 9.65 9.65 45,545
Aug 21, 2026 10.33 10.95 10.00 10.52 10.52 59,939
Aug 20, 2026 10.70 10.81 9.64 10.21 10.21 182,664
Aug 19, 2026 10.35 10.93 9.85 10.81 10.81 74,454
Aug 18, 2026 10.26 10.54 10.02 10.27 10.27 47,225
Aug 17, 2026 10.15 10.68 10.00 10.25 10.25 144,327
Aug 14, 2026 9.71 10.39 9.68 9.97 9.97 119,800
Aug 13, 2026 9.53 10.05 8.74 9.94 9.94 109,366
Aug 12, 2026 9.00 9.50 8.72 9.40 9.40 81,157
Aug 11, 2026 8.79 9.37 8.66 9.12 9.12 76,563
Aug 10, 2026 8.02 8.99 7.68 8.96 8.96 51,679
Aug 7, 2026 6.70 8.82 6.35 8.09 8.09 214,319
Aug 6, 2026 6.36 6.71 5.80 6.70 6.70 203,897
Aug 5, 2026 6.36 6.56 6.10 6.53 6.53 25,887
Aug 4, 2026 6.00 6.68 6.00 6.23 6.23 197,905
Aug 3, 2026 6.03 6.33 5.74 6.09 6.09 144,031
Jul 31, 2026 6.24 6.33 5.98 6.08 6.08 37,061
Jul 30, 2026 6.14 6.61 6.01 6.29 6.29 59,412
Jul 29, 2026 6.10 6.38 5.97 6.07 6.07 56,124
Jul 28, 2026 6.02 6.42 6.00 6.09 6.09 25,129
Jul 27, 2026 6.27 6.42 5.88 6.05 6.05 31,461
Jul 24, 2026 6.65 6.65 5.95 6.19 6.19 30,260
Jul 23, 2026 6.31 6.91 6.10 6.37 6.37 40,089
Jul 22, 2026 6.42 6.51 6.01 6.33 6.33 48,347
Jul 21, 2026 6.11 6.51 5.99 6.40 6.40 78,223
Jul 20, 2026 5.99 6.25 5.73 6.07 6.07 42,079
Jul 17, 2026 5.69 6.25 5.63 5.88 5.88 38,841
Jul 16, 2026 6.00 6.23 5.72 5.78 5.78 73,441
Jul 15, 2026 6.25 6.29 5.89 6.03 6.03 66,330
Jul 14, 2026 6.54 6.75 6.00 6.15 6.15 83,124
Jul 13, 2026 6.59 6.77 6.37 6.52 6.52 35,584
Jul 10, 2026 6.64 7.05 6.54 6.59 6.59 30,607
Jul 9, 2026 6.60 6.76 6.05 6.64 6.64 156,439
Jul 8, 2026 7.69 7.92 6.30 6.53 6.53 323,888
Jul 7, 2026 8.25 8.30 7.72 7.91 7.91 146,784
Jul 6, 2026 8.85 9.53 7.68 8.28 8.28 79,755
Jul 2, 2026 8.84 8.93 7.91 8.77 8.77 54,319
Jul 1, 2026 8.49 8.96 8.06 8.30 8.30 113,687
Jun 30, 2026 8.10 8.72 7.88 8.64 8.64 56,044
Jun 29, 2026 7.99 8.50 7.70 8.12 8.12 129,019
Jun 26, 2026 6.98 8.07 6.89 7.84 7.84 64,458
Jun 25, 2026 7.67 7.78 7.19 7.19 7.19 64,832
Jun 24, 2026 8.45 8.99 7.54 7.57 7.57 85,504
Jun 23, 2026 7.98 8.54 7.93 8.35 8.35 65,177
Jun 22, 2026 8.39 8.65 8.00 8.12 8.12 78,479
Jun 18, 2026 8.74 8.84 7.85 8.43 8.43 135,550
Jun 17, 2026 8.60 9.03 8.50 8.70 8.70 43,962
Jun 16, 2026 9.18 9.52 8.48 8.68 8.68 134,218
Jun 15, 2026 10.44 10.49 9.07 9.11 9.11 159,147
Jun 12, 2026 10.17 10.45 9.80 10.25 10.25 153,529
Jun 11, 2026 9.86 10.34 9.46 10.18 10.18 67,171
Jun 10, 2026 9.45 10.40 9.30 9.93 9.93 168,543
Jun 9, 2026 9.64 10.03 8.70 9.52 9.52 118,912
Jun 8, 2026 8.97 9.66 8.72 9.64 9.64 131,697
Jun 5, 2026 9.90 9.99 8.55 8.72 8.72 136,425
Jun 4, 2026 9.72 10.13 9.03 9.94 9.94 422,867
Jun 3, 2026 9.31 10.09 9.20 9.86 9.86 133,499
Jun 2, 2026 10.10 10.11 8.58 9.45 9.45 198,563
Jun 1, 2026 9.99 10.37 9.31 10.35 10.35 96,214
May 29, 2026 9.19 10.27 9.08 9.76 9.76 347,018
May 28, 2026 9.24 9.36 8.79 9.24 9.24 222,017
May 27, 2026 8.95 9.68 8.65 9.24 9.24 316,595
May 26, 2026 6.79 9.23 6.69 8.91 8.91 618,593
May 22, 2026 5.96 6.79 5.96 6.67 6.67 129,747
May 21, 2026 6.01 6.07 5.70 5.99 5.99 41,740
May 20, 2026 5.95 6.18 5.89 6.13 6.13 26,066
May 19, 2026 5.83 6.13 5.80 5.91 5.91 34,156
May 18, 2026 6.30 6.35 5.70 5.86 5.86 75,643
May 15, 2026 6.27 6.40 5.72 6.27 6.27 182,554
May 14, 2026 6.32 6.64 6.05 6.43 6.43 86,099
May 13, 2026 6.75 6.75 6.17 6.32 6.32 59,001
May 12, 2026 6.62 6.87 6.51 6.70 6.70 70,690
May 11, 2026 6.34 6.65 6.16 6.61 6.61 61,636
May 8, 2026 6.26 6.52 6.17 6.41 6.41 71,003
May 7, 2026 6.58 6.88 6.17 6.27 6.27 62,282
May 6, 2026 7.08 7.08 6.65 6.66 6.66 19,171
May 5, 2026 6.80 7.34 6.38 6.99 6.99 92,332
May 4, 2026 6.69 6.83 6.30 6.68 6.68 37,900
May 1, 2026 6.60 6.88 6.35 6.64 6.64 69,698
Apr 30, 2026 6.19 6.64 5.97 6.51 6.51 80,130
Apr 29, 2026 6.17 6.34 5.93 6.15 6.15 88,581
Apr 28, 2026 6.05 6.24 5.85 6.15 6.15 36,000
Apr 27, 2026 6.10 6.44 6.01 6.07 6.07 22,685
Apr 24, 2026 6.09 6.25 6.02 6.17 6.17 19,966
Apr 23, 2026 6.52 6.52 6.01 6.18 6.18 33,860
Apr 22, 2026 6.21 6.34 6.11 6.12 6.12 25,446
Apr 21, 2026 6.28 6.55 6.01 6.20 6.20 63,585
Apr 20, 2026 6.46 6.55 6.26 6.31 6.31 15,998
Apr 17, 2026 6.73 7.04 6.45 6.50 6.50 33,145
Apr 16, 2026 6.79 6.95 6.50 6.68 6.68 29,458
Apr 15, 2026 6.66 6.79 6.40 6.79 6.79 38,266
Apr 14, 2026 6.28 6.76 6.28 6.55 6.55 50,588
Apr 13, 2026 6.02 6.45 6.00 6.29 6.29 34,923
Apr 10, 2026 6.70 7.12 5.71 6.08 6.08 149,069
Apr 9, 2026 7.11 7.32 6.42 6.65 6.65 170,117
Apr 8, 2026 6.97 6.98 6.19 6.21 6.21 78,711
Apr 7, 2026 6.95 6.95 6.61 6.71 6.71 20,296
Apr 6, 2026 6.84 7.45 6.71 7.04 7.04 89,528
Apr 2, 2026 6.49 6.87 6.25 6.80 6.80 132,022
Apr 1, 2026 6.05 6.80 6.05 6.60 6.60 216,916
Mar 31, 2026 5.85 6.12 5.69 6.03 6.03 22,028
Mar 30, 2026 5.86 5.88 5.62 5.64 5.64 18,336
Mar 27, 2026 6.03 6.32 5.77 5.86 5.86 58,692
Mar 26, 2026 6.52 6.93 5.83 6.02 6.02 49,943
Mar 25, 2026 6.25 6.98 6.01 6.69 6.69 45,047
Mar 24, 2026 6.03 6.42 5.87 6.17 6.17 54,445
Mar 23, 2026 6.26 6.56 5.56 6.13 6.13 85,224
Mar 20, 2026 6.41 6.44 5.97 6.25 6.25 186,990
Mar 19, 2026 6.66 6.95 6.26 6.55 6.55 166,443
Mar 18, 2026 6.95 7.00 6.60 6.90 6.90 48,994
Mar 17, 2026 6.61 7.27 6.32 6.81 6.81 75,965
Mar 16, 2026 6.26 6.66 6.26 6.29 6.29 38,330
Mar 13, 2026 6.46 6.50 6.00 6.14 6.14 24,471
Mar 12, 2026 6.30 6.39 6.04 6.33 6.33 29,751
Mar 11, 2026 6.41 6.85 6.34 6.40 6.40 52,677
Mar 10, 2026 6.56 6.74 6.34 6.50 6.50 29,653
Mar 9, 2026 6.71 6.89 5.75 6.64 6.64 55,610
Mar 6, 2026 7.31 7.41 6.80 6.85 6.85 47,171
Mar 5, 2026 7.81 8.21 7.13 7.52 7.52 45,694
Mar 4, 2026 7.63 8.16 7.54 7.97 7.97 77,616
Mar 3, 2026 7.25 7.75 6.44 7.61 7.61 100,211
Mar 2, 2026 7.28 7.78 6.55 7.77 7.77 50,230
Feb 27, 2026 7.50 7.58 6.91 7.58 7.58 55,013
Feb 26, 2026 7.28 7.74 7.05 7.74 7.74 49,318
Feb 25, 2026 7.21 7.32 6.88 7.28 7.28 54,275
Feb 24, 2026 6.67 7.19 6.27 7.18 7.18 60,536
Feb 23, 2026 6.12 6.74 6.12 6.66 6.66 39,178
Feb 20, 2026 6.03 6.25 6.00 6.25 6.25 42,306
Feb 19, 2026 6.02 6.22 5.86 6.17 6.17 45,123
Feb 18, 2026 6.14 6.43 5.85 6.01 6.01 21,901
Feb 17, 2026 5.43 6.89 5.43 6.14 6.14 137,332
Feb 13, 2026 5.63 5.92 5.41 5.43 5.43 41,406
Feb 12, 2026 5.51 5.59 5.30 5.59 5.59 21,233
Feb 11, 2026 5.39 5.68 5.15 5.46 5.46 46,138
Feb 10, 2026 5.36 5.73 5.27 5.36 5.36 43,459
Feb 9, 2026 5.46 5.59 5.18 5.35 5.35 36,730
Feb 6, 2026 5.10 5.57 5.10 5.45 5.45 25,990
Feb 5, 2026 5.50 5.65 5.07 5.07 5.07 50,022
Feb 4, 2026 6.09 6.11 5.51 5.55 5.55 32,381
Feb 3, 2026 6.55 6.81 6.02 6.07 6.07 31,941
Feb 2, 2026 6.66 7.11 6.55 6.55 6.55 61,709
Jan 30, 2026 7.10 7.44 6.55 6.66 6.66 63,952
Jan 29, 2026 7.25 7.56 7.03 7.10 7.10 26,775
Jan 28, 2026 7.95 7.97 7.02 7.25 7.25 127,669
Jan 27, 2026 8.08 8.30 7.60 7.88 7.88 52,006
Jan 26, 2026 7.41 8.18 7.01 8.15 8.15 102,960
Jan 23, 2026 7.07 7.55 6.76 7.47 7.47 87,573
Jan 22, 2026 7.62 7.91 6.73 7.04 7.04 98,652
Jan 21, 2026 6.88 8.00 6.40 7.58 7.58 224,132
Jan 20, 2026 7.00 7.45 6.87 6.88 6.88 121,513
Jan 16, 2026 6.74 7.29 6.55 7.14 7.14 156,838
Jan 15, 2026 6.60 7.07 6.41 6.79 6.79 194,543
Jan 14, 2026 6.24 6.64 5.57 6.55 6.55 83,666
Jan 13, 2026 6.35 6.67 6.15 6.29 6.29 131,936
Jan 12, 2026 5.52 6.35 5.44 6.33 6.33 268,745
Jan 9, 2026 5.10 5.69 5.05 5.63 5.63 65,571
Jan 8, 2026 4.65 5.15 4.65 5.03 5.03 30,076
Jan 7, 2026 4.86 4.93 4.75 4.85 4.85 16,218
Jan 6, 2026 4.74 4.96 4.74 4.87 4.87 34,633
Jan 5, 2026 4.57 4.78 4.49 4.73 4.73 16,239
Jan 2, 2026 4.49 4.69 4.45 4.55 4.55 22,003
Dec 31, 2025 4.66 4.75 4.42 4.49 4.49 75,019
Dec 30, 2025 4.80 4.93 4.61 4.65 4.65 48,746
Dec 29, 2025 4.80 5.00 4.77 4.77 4.77 37,775
Dec 26, 2025 4.84 4.96 4.80 4.95 4.95 19,112
Dec 24, 2025 4.79 4.95 4.75 4.88 4.88 16,344
Dec 23, 2025 4.86 4.89 4.61 4.80 4.80 52,291
Dec 22, 2025 4.59 4.99 4.51 4.95 4.95 51,944
Dec 19, 2025 4.57 4.81 4.47 4.60 4.60 53,106
Dec 18, 2025 4.80 5.06 4.41 4.42 4.42 142,697
Dec 17, 2025 4.84 4.84 4.77 4.78 4.78 19,048
Dec 16, 2025 4.77 4.86 4.71 4.79 4.79 39,268
Dec 15, 2025 4.83 4.98 4.77 4.77 4.77 31,914
Dec 12, 2025 4.83 4.89 4.75 4.75 4.75 23,281
Dec 11, 2025 4.80 4.92 4.79 4.82 4.82 20,232
Dec 10, 2025 4.95 4.97 4.78 4.78 4.78 29,344
Dec 9, 2025 4.84 5.09 4.82 4.90 4.90 86,633
Dec 8, 2025 4.98 4.98 4.84 4.90 4.90 20,218
Dec 5, 2025 4.92 5.03 4.80 4.82 4.82 9,759
Dec 4, 2025 5.00 5.11 4.91 4.95 4.95 38,060
Dec 3, 2025 4.82 5.00 4.74 5.00 5.00 18,863
Dec 2, 2025 4.76 4.84 4.73 4.75 4.75 13,180
Dec 1, 2025 5.05 5.05 4.75 4.77 4.77 32,369
Nov 28, 2025 4.96 5.09 4.90 5.05 5.05 11,310
Nov 26, 2025 4.77 5.14 4.77 4.90 4.90 75,957
Nov 25, 2025 4.81 4.97 4.81 4.93 4.93 14,995
Nov 24, 2025 4.82 4.98 4.75 4.80 4.80 34,867
Nov 21, 2025 4.62 4.78 4.53 4.71 4.71 25,777
Nov 20, 2025 4.98 5.00 4.59 4.59 4.59 49,644
Nov 19, 2025 5.08 5.08 4.83 4.88 4.88 38,081
Nov 18, 2025 5.11 5.19 5.03 5.05 5.05 26,850
Nov 17, 2025 5.56 5.56 5.16 5.26 5.26 52,393
Nov 14, 2025 5.53 5.71 5.20 5.60 5.60 38,477
Nov 13, 2025 6.05 6.24 5.65 5.71 5.71 60,966
Nov 12, 2025 6.30 6.61 6.05 6.06 6.06 84,677
Nov 11, 2025 6.26 6.39 6.06 6.30 6.30 82,062
Nov 10, 2025 5.90 6.35 5.72 6.22 6.22 135,450
Nov 7, 2025 5.90 6.26 5.50 5.83 5.83 309,386
Nov 6, 2025 4.97 6.00 4.75 5.84 5.84 396,796
Nov 5, 2025 4.95 4.96 4.47 4.74 4.74 62,619
Nov 4, 2025 5.01 5.10 4.88 4.95 4.95 29,327
Nov 3, 2025 5.01 5.17 4.98 5.08 5.08 41,145
Oct 31, 2025 4.90 5.08 4.88 5.04 5.04 18,235
Oct 30, 2025 4.90 5.02 4.88 4.88 4.88 18,193
Oct 29, 2025 4.95 5.19 4.91 5.04 5.04 49,767
Oct 28, 2025 4.88 4.96 4.86 4.86 4.86 19,439
Oct 27, 2025 5.01 5.09 4.87 4.90 4.90 17,664
Oct 24, 2025 4.93 5.05 4.89 4.98 4.98 48,656
Oct 23, 2025 4.84 4.97 4.83 4.90 4.90 22,757
Oct 22, 2025 4.95 5.02 4.71 4.83 4.83 71,122
Oct 21, 2025 5.02 5.17 4.91 4.97 4.97 64,353
Oct 20, 2025 4.92 5.24 4.92 5.03 5.03 43,775
Oct 17, 2025 5.01 5.23 4.83 4.91 4.91 26,927
Oct 16, 2025 5.16 5.26 5.02 5.02 5.02 18,179
Oct 15, 2025 5.20 5.26 5.00 5.14 5.14 53,812
Oct 14, 2025 4.92 5.17 4.80 5.12 5.12 28,207
Oct 13, 2025 5.01 5.13 4.89 5.00 5.00 53,102
Oct 10, 2025 5.27 5.38 4.97 5.00 5.00 44,046
Oct 9, 2025 5.17 5.30 5.14 5.26 5.26 61,081
Oct 8, 2025 4.98 5.18 4.92 5.15 5.15 71,124
Oct 7, 2025 4.94 5.01 4.86 4.95 4.95 37,057
Oct 6, 2025 4.98 5.18 4.86 5.01 5.01 64,782
Oct 3, 2025 5.21 5.28 4.95 5.01 5.01 52,663
Oct 2, 2025 4.95 5.19 4.92 5.12 5.12 67,974
Oct 1, 2025 4.92 5.05 4.78 4.94 4.94 20,331
Sep 30, 2025 5.01 5.04 4.88 4.95 4.95 29,166
Sep 29, 2025 4.95 5.05 4.76 4.90 4.90 31,380
Sep 26, 2025 4.82 5.10 4.75 4.93 4.93 84,932
Sep 25, 2025 5.07 5.10 4.80 4.82 4.82 56,076
Sep 24, 2025 5.12 5.29 5.00 5.15 5.15 35,263
Sep 23, 2025 5.12 5.25 4.99 5.17 5.17 47,707

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
electroCore, Inc. Common Stock Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at ECOR, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation